Show simple item record

dc.contributor.authorDelgado-Arévalo, Cristina
dc.contributor.authorCalvet-Mirabent, Marta
dc.contributor.authorTriguero-Martinez, Ana
dc.contributor.authorVázquez de Luis, Enrique
dc.contributor.authorBenguría-Filippini, Alberto
dc.contributor.authorLargo, Raquel
dc.contributor.authorCalzada-Fraile, Diego
dc.contributor.authorPopova, Olga
dc.contributor.authorSánchez-Cerrillo, Ildefonso
dc.contributor.authorTsukalov, Ilya
dc.contributor.authorMoreno-Vellisca, Roberto
dc.contributor.authorde la Fuente, Hortensia 
dc.contributor.authorHerrero-Beaumont, Gabriel
dc.contributor.authorRamiro, Almudena R 
dc.contributor.authorSánchez-Madrid, Francisco
dc.contributor.authorCastañeda, Santos
dc.contributor.authorDopazo, Ana 
dc.contributor.authorGonzález-Álvaro, Isidoro
dc.contributor.authorMartin-Gayo, Enrique
dc.date.accessioned2022-11-14T13:10:36Z
dc.date.available2022-11-14T13:10:36Z
dc.date.issued2022-10-04
dc.identifier.citationJCI Insight . 2022 Oct 4;e152886. doi: 10.1172/jci.insight.152886.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15128
dc.description.abstractThe individual contribution of specific myeloid subsets such as CD1c+ conventional dendritic cells (cDC) to perpetuation of Rheumatoid Arthritis (RA) pathology remains unclear. In addition, the specific innate sensors driving pathogenic activation of CD1c+ cDCs in RA patients and their functional implications have not been characterized. Here, we assessed phenotypical, transcriptional and functional characteristics of CD1c+ and CD141+ cDCs and monocytes from the blood and synovial fluid of RA patients. Increased levels of CCR2 and the IgG receptor CD64 on circulating CD1c+ cDC associated with the presence of this DC subset in the synovial membrane in RA patients. Moreover, synovial CD1c+ cDCs are characterized by increased expression of proinflammatory cytokines and high abilities to induce pathogenic IFNγ+IL-17+ CD4+ T cells in vitro. Finally, we identified the crosstalk between Fcγ Receptors and NLRC4 as a new potential molecular mechanism mediating pathogenic activation, CD64 upregulation and functional specialization of CD1c+ cDCs in response to dsDNA-IgG in RA patients.es_ES
dc.description.sponsorshipE.M.G. was supported by Comunidad de Madrid Talento Program (2017-T1/BMD5396), Ramón y Cajal Program (RYC2018-024374-I), the MINECO RETOS program (RTI2018-097485-A-I00), La Caixa Foundation (HR20-00218), CIBERINF (CB21/13/00107) and the TV3 Marató (REDINCOV). C.D.A. was supported by Comunidad de Madrid Talento Program (2017-T1/BMD-5396). M.C.M was supported by the NIH (R21AI140930). HR17-00016 grant from “La Caixa Banking Foundation to F.S.M also supported the study. D.C-F. is supported by the Fellowship “la Caixa” Foundation LCF/BQ/DR19/11740010. A.T.M. was supported by a PhD fellowship from the Autonomous Region of Madrid (PEJD-2019-PRE/BMD-16851) and the RD21/0002/0027 grant. R.L. and G.H.B. were supported by PI18/00261 AND PI20/00349 grants from Ministerio de Ciencia e Innovación and Instituto de Salud Carlos III, respectively. O.P. was supported by the TV3 Marató (REDINCOV) and I.T. was funded by grant for the promotion of research studies master-UAM 2021. S.C. was supported by PI21/01474 grant from the Instituto de Salud Carlos III and co-funded by The European Regional Development Fund (ERDF). I.G.A was supported by RD21/0002/0027 and PI21/00526 grants from the Spanish MINECO and Instituto de Salud Carlos III and co-funded by The European Regional Development Fund (ERDF) “A way to make Europe.es_ES
dc.language.isoenges_ES
dc.publisherAmerican Society for Clinical Investigation (ASCI) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleNLRC4 -mediated activation of CD1c+ dendritic cells contributes to perpetuation of synovitis in rheumatoid arthritis.es_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID36194479es_ES
dc.identifier.doi10.1172/jci.insight.152886es_ES
dc.contributor.funderComunidad de Madrid (España) es_ES
dc.contributor.funderMinisterio de Economía y Competitividad (España) es_ES
dc.contributor.funderFundación La Caixa es_ES
dc.contributor.funderFundación La Marató TV3 es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España) es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn2379-3708es_ES
dc.relation.publisherversionDOI: 10.1172/jci.insight.152886es_ES
dc.identifier.journalJCI insightes_ES
dc.repisalud.orgCNICCNIC::Unidades técnicas:: Unidad de Genómicaes_ES
dc.repisalud.institucionCNICes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/2017-T1/BMD5396es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RYC2018-024374-Ies_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RTI2018-097485-A-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/HR20-00218es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CB21/13/00107es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/REDINCOVes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/2017-T1/BMD-5396es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/HR17-00016es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/LCF/BQ/DR19/11740010es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PEJD-2019-PRE/BMD-16851es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RD21/0002/0027es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI18/00261es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI20/00349es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI21/00526es_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional